The 20 Best Choriocarcinoma Doctors in Arizona, US

Dr. Dyer is committed to providing the highest quality and compassionate care to both his male and female patients.  He enjoys spending time and interacting with each patient.  Each individual is unique and every treatment option is tailored towards their specific need based on a thorough history and decision making process. Dr. Dyer is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Erectile Dysfunction (ED), Urinary Tract Infection in Children, Ureteroscopy, and Reconstructive Urology Surgery.

Dr. Puneet Bhalla is a board certified Medical Oncologist and joined Ironwood Cancer & Research Centers in September 2006. Dr. Bhalla is a graduate of Bangalore Medical College, Bangalore University. He completed his Internal Medicine residency and Medical Oncology fellowship from William Beaumont Hospital, Royal Oak, Michigan. His research has been published in national and international oncology meetings and he remains actively involved in research at Ironwood Cancer & Research Centers. He has been practicing in the East Valley since 2003, initially in solo practice and since 2006 as part of Ironwood Cancer & Research Centers. He also serves on the Dignity Health East Valley Board of Directors for Mercy Gilbert and Chandler Regional Hospitals.A strong patient advocate, he routinely picks up the phone to communicate with other physicians and health insurance companies on his patients behalf. He has been nominated as Top Doc in medical oncology by his peers several times in Phoenix Magazine. As an extended faculty at Midwestern University he mentors medical students during their Oncology rotations. He is well respected by his peers in the community for his expertise in solid tumors.He lives in the Phoenix area with his wife and twin daughters and dog Frodo! In his spare time, he may be seen hiking with his family, riding his road bike or camping in the AZ high country. Dr. Bhalla is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Myelodysplastic Syndrome (MDS), and Familial Colorectal Cancer.

Dr. Kalmadi joined Ironwood Cancer and Research Centers in 2008 and serves as Chief Medical Officer.  After finishing his medical schooling in India, Dr. Sujith Kalmadi completed his residency training and fellowship at the Cleveland Clinic in Cleveland, Ohio. He then served as academic clinical faculty at the Cleveland Clinic School of Medicine (Lerner School) in Cleveland, Ohio and subsequently at Baylor College of Medicine in Houston, Texas. During his tenure at these prestigious institutions, he pioneered several novel clinical research trials which have been lauded at national scientific meetings and published in peer reviewed journals. His areas of clinical and research interests include several solid tumors and hematological disorders. He currently resides in Chandler with his wife and three children, and enjoys tennis, chess and racquetball during his spare time. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Kalmadi is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Lung Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Severe Congenital Neutropenia.

Dr. Cherington joined Ironwood Cancer &  Research Centers in July 2016 after completing his fellowship in Hematology and Medical Oncology at the Mayo clinic.  An Arizona native, he earned undergraduate degrees in Biology and Spanish at Arizona State University prior to attending the University of Arizona for his medical doctorate.  Dr. Cherington has presented research at ASCO and ASH and authored several research articles. However, what he values most is receiving the Gold Humanism Award, which recognizes him as possessing the personal characteristics that colleagues themselves would look for in a physician for themselves or their family members. Early in his youth, Dr. Cherington developed a passion to fight cancer when a childhood friend was diagnosed with a rare brain tumor.  His friend's cancer was aggressive, and her life was ultimately lost, but her tumor cells were donated to research new therapies. Years later, Dr. Cherington spent time at Barrow Neurological Institute investigating cell lines that most likely included his friend's saved cells. The fire that was ignited as a child was further fueled when Dr. Cherington's step-sister lost her life to cancer as a young adult. Today, in each new patient, Dr. Cherington sees a friend or family member who deserves the utmost compassion and expertise that modern medicine has to offer.Outside of work, Dr. Cherington enjoys hiking, exploring Arizona, sports, and spending time with his three children, his dog, and his beautiful wife.  Together, they are passionate about continually moving toward adopting lifestyle factors to prevent or slow cancer.  Dr. Cherington promotes using healthful lifestyle changes in conjunction with the best cancer treatment modern medicine has to offer to continually work towards a cure. Dr. Cherington is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Oligodendroglioma, Astrocytoma, Glioblastoma, and Gliosarcoma.

Dr. Halbur joined Ironwood Cancer & Research Centers in 2005, following his residency in Internal Medicine and fellowship in Hematology and Oncology at the University of California at Irvine. He earned his medical degree at Loyola University of Chicago, Stritch School of Medicine. Dr. Halbur has been active in cancer research and has presented his results at the American Society of Hematology Annual Meeting. He has also been involved in clinical trial development. Dr. Halbur lives in the East Valley and enjoys spending time with his wife and two daughters. His hobbies include playing basketball, tennis, and golf and cheering on the Suns. He is board certified in Internal Medicine, Hematology and Medical Oncology.Supportive Cancer Care You Can Trust You can find that team at Ironwood Cancer & Research Centers. With community-based centers strategically located throughout the Metro Phoenix area, Ironwood offers advanced therapies and a multi-disciplinary approach usually associated with large academic centers – but with a personalized touch recognizing the individual needs of the patient.Studies have shown the importance of a multi-disciplinary approach in effectively treating cancer. We spare you time and worry simply by having all the doctors, therapists, and resources you need in one convenient location, eliminating the delays and miscommunication. These collaborative efforts ensure the highest standards of care. Because Ironwood is actively involved in cutting-edge research, you can also benefit from promising new treatments through participation in clinical trials. We evaluate you and develop a personalized treatment plan specifically for you to insure the best possible outcome. Dr. Halbur is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Familial Colorectal Cancer, Adult Soft Tissue Sarcoma, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes.

Dr. DeRoock joined Ironwood Cancer & Research Centers in 2009 after completing residency in Internal Medicine followed by fellowship in Hematology and Oncology at the University of California at Davis. He is a first-generation Panamanian-American fluent in both English and Spanish. He previously earned his medical degree at the University of Arizona. Dr. DeRoock is board certified in Internal Medicine, Hematology and Medical Oncology. He has been active in developing clinical trials for pancreatic cancer and lymphoma, and has presented his research findings at the American Society of Hematology Annual Meeting as well as the Annual Pan-Pacific Lymphoma Conference. He specializes in all adult cancers and hematologic disorders.Supportive Cancer Care You Can TrustYou can find that team at Ironwood Cancer & Research Centers. With community-based centers strategically located throughout the Metro Phoenix area, Ironwood offers advanced therapies and a multi-disciplinary approach usually associated with large academic centers – but with a personalized touch recognizing the individual needs of the patient.Studies have shown the importance of a multi-disciplinary approach in effectively treating cancer. We spare you time and worry simply by having all the doctors, therapists, and resources you need in one convenient location, eliminating the delays and miscommunication. These collaborative efforts ensure the highest standards of care. Because Ironwood is actively involved in cutting-edge research, you can also benefit from promising new treatments through participation in clinical trials. Dr. Deroock is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Pulmonary Embolism, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.

I enjoy art, cooking, music and spending time with family. Dr. Wong is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes.

Paul Gellhaus is a Urologist in Goodyear, Arizona. Dr. Gellhaus is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Ureterocele, Nephrectomy, and Reconstructive Urology Surgery. Dr. Gellhaus is currently accepting new patients.

Kalyan Mantripragada is a Hematologist in Gilbert, Arizona. Dr. Mantripragada is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Pulmonary Embolism, Hemochromatosis, Agranulocytosis, Childhood Iron Deficiency Anemia, and Gallbladder Removal. Dr. Mantripragada is currently accepting new patients.

His approach is centered on providing personalized, comprehensive care to each of his patients. He holds certification from the American Board of Urology and is a member of the American Urological Association. Dr. Avila is also bilingual, speaking both English and Spanish. Dr. Avila is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Peyronie Disease, Enlarged Prostate (BPH), Perirenal Abscess, Hormone Replacement Therapy (HRT), and Reconstructive Urology Surgery.

Dr. Sumeet Mendonca joined Ironwood Cancer & Research Centers in January 2012. On completion of her training in Hematology/Medical Oncology at St Elizabeth Medical Center, Tufts University, Boston, Dr. Sumeet Kumar Mendonca joined Desert Oncology Associates in 2008, now part of Ironwood Cancer and Research Centers. Being part of an expatriate family she received a global educational imprint in places like India, Singapore and Nigeria. On completion of Medical School in MGM, Mumbai University, India she dedicated two years to research in the field of Cancer Immunotherapy at the University of Connecticut Health Center. Her work was very well received and resulted in a number of publications in several peer reviewed journals. Dr Mendonca is board certified in Internal Medicine and Medical Oncology and treats all forms of adult cancers with a key interest in solid tumors, including breast cancer. She has been a prominent advocate for the promotion of women's health, focusing on prevention, early diagnosis and treatment of breast cancer. Dr. Mendonca's special interests are in delivering individualized care in a comprehensive and compassionate manner. Dr. Mendonca is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Severe Congenital Neutropenia, and Chronic Familial Neutropenia.

I'm actively involved in oncology patient care, in pre- and postdoctoral education, and in teaching graduate students, house staff and fellows. Dr. Gelmann is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Prostate Cancer, Urothelial Cancer, Familial Prostate Cancer, and Bladder Cancer.

Joining Ironwood Cancer & Research Centers in 2004, Dr. Shtivelband received his medical degree and PhD in Experimental Hematology in Russia. After Internal Medicine Residency, Dr. Shtivelband received fellowship training in Hematology and Medical Oncology at MD Anderson Cancer Center in Houston, where he stayed for an additional year to participate in experimental research. Treating patients with all kinds of malignancies and benign hematological problems, Dr. Shtivelband has particular interest in developing research programs to bring the newest advances in the field of Oncology and Hematology to our community. Dr. Shtivelband also heads the Ironwood Cancer & Research Center's research program. He is Board Certified in Internal Medicine, Hematology and Medical Oncology. Dr. Shtivelband is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Hemochromatosis, Non-Small Cell Lung Cancer (NSCLC), Plasmacytoma, and Lung Cancer.

Dr. Michael Musci joined Ironwood Cancer & Research Centers in June 2007 as a Medical Oncologist. He comes to us from Kaiser Permanente Oncology Department in Walnut Creek, California. Dr. Musci received his medical degree and PhD at the University of Iowa. After Internal Medicine Residency, Dr. Musci received fellowship training in Hematology Oncology at UCSD Medical Center in San Diego, California. Dr. Musci is Board Certified in Internal Medicine, Hematology and Medical Oncology. Dr. Musci is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Pleuropulmonary Blastoma, Familial Colorectal Cancer, Severe Congenital Neutropenia, and Lung Cancer.

Dr. Anita Koszyk-Szewczyk joined Ironwood Cancer & Research Centers in July 2009, after completing her Hematology and Oncology training at Penn State University Hershey Medical Center. Dr.Szewczyk has earned her medical degree at Jagiellonian University Collegium Medicum in Krakow, Poland and Honours Biology at McMaster University Hamilton, Canada. She served as Chief Fellow at Penn State University and her special interests include all forms of adult cancers and hematological disorders with special interest in Breast Cancer. She is originally from Poland and Canada. She is board certified in Internal Medicine, Hematology and Oncology. Dr. Koszyk is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Bone Marrow Aspiration.

George Kallingal is an Oncologist and a Urologist in Phoenix, Arizona. Dr. Kallingal is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kallingal is currently accepting new patients.

Bruce Kletscher is a Urologist in Phoenix, Arizona. Dr. Kletscher is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Perirenal Abscess, Carbuncle, Boils, Folliculitis, and Ureteroscopy. Dr. Kletscher is currently accepting new patients.

Dr. Ortiz Cruz joined Ironwood Cancer & Research Center in September 2014, after completing her hematology and medical oncology fellowship at the University of South Carolina in Charleston. She completed two years of research at the National Cancer Institute | National Institutes of Health in Bethesda Maryland where she was involved with clinical research in radiation oncology in addition to work with medical oncology. Dr. Ortiz Cruz also completed an internal medicineresidency training program at Banner Good Samaritan Medical Center in Phoenix. She has published several articles in scientific journals and presented at various meetings. Dr. Cruz's specializes in solid tumor and hematologic disorders with a special interest in breast, colon cancer and lymphoma. Dr. Cruz's goal is to deliver the best care available for her patients by providing personalized treatment planning in conjunction with cutting-edge therapy.Dr. Cruz's personal goal is to deliver the best care available for her patients with the understanding that personalized treatment planning in conjunction with utilizing cutting-edge therapy is the best means to achieve this goal. Dr. Cruz is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. Her top areas of expertise are Breast Cancer, Severe Congenital Neutropenia, Paget Disease of the Breast, and Chronic Familial Neutropenia.

Dr. Manuel Eisenberg is a fellowship-trained urologist in the treatment of the urologic cancers including cancer of the prostate, kidney, testicles, and bladder. He is fully versed in advanced robotic, laparoscopic, and open surgical techniques allowing him to offer the optimal individualized treatment approach on a patient-by-patient basis. Dr. Eisenberg has spent his career helping patients through the difficult time of a cancer diagnosis and treatment. He seeks to make sure every patient understands their disease and the treatment options available to them. In doing so, he ensures that every person can make a truly educated decision on what treatment best suits his or her individual needs. Dr. Eisenberg has worked side-by-side with the leaders in the field of urologic cancer surgery as well as Radiation and Medical Oncology. Along with his colleagues at the Ironwood Cancer & Research Centers, he believes in a multidisciplinary approach to give all patients the optimal treatments based on the stage of their disease and their personal preferences.  In addition to his emphasis on urologic cancers, Dr. Eisenberg is fully trained in general urology and offers the latest treatments in benign prostatic hyperplasia (BPH), kidney stone disease, urinary problems, hypogonadism (low testosterone), erectile dysfunction, hematuria (blood in the urine), and urinary incontinence (leakage of urine).  Dr. Eisenberg graduated as a Regents Scholar from the University of California, Berkeley and then attended the University of California, San Francisco School of Medicine where he was inducted into the Alpha Omega Alpha (AOA) medical school honor society. He completed his internship in general surgery at the University of Southern California/Los Angeles County Medical Center, and his Urology training at the USC Institute of Urology. Dr. Eisenberg then completed a 2-year Society of Urologic Oncologist (SUO) accredited fellowship in Urologic Oncology at the world-renowned Mayo Clinic in Rochester, Minnesota. Dr. Eisenberg has published over 20 scientific journal articles, several book chapters, and presented at numerous conferences across the country.Ironwood Urology is committed to providing the highest quality patient care in a compassionate, safe and patient-focused manner.In addition, our care is fully integrated with your primary care physician. In doing so, we maintain ongoing communication with your personal physician(s) to ensure you are receiving the best care possible.Using state-of-the-art techniques and equipment, Ironwood Urology specially trained urological surgeons offer hope to those suffering from any urological condition, from the simplest problem to the most complex.We believe that our education and missions serve to enhance excellence in patient care and distinguish us for the quality outcomes we provide. Dr. Eisenberg is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Bladder Cancer, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Cystectomy, and Reconstructive Urology Surgery.

I enjoy traveling and cycling. Dr. Swart is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Angiosarcoma.